 AngioDynamics, Inc. NASDAQ: ANGO, a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the enrollment of the first patient in the PATHFINDER I: Post-Market Registry PATHFINDER I-Registry, EX-PAD-05. 